Investor Information

Financial Overview

As at August 28, 2020 there were 121,086,516 common shares issued and outstanding.

Stock Options

At August 28, 2020 the following common share purchase options were outstanding:

Expiry Date Number Outstanding Exercise Price Number Exercisable (Vested)
May 4, 2021 1,355,000 0.05 1,355,000
June 28, 2018 75,000 0.10 75,000
January 9, 2022 2,250,000 0.17 2,250,000
February 26, 2023 2,100,000 0.15 2,100,000
September 4, 2024 1,530,000 0.07 510,000
  7,310,000  0.10 6,290,000

Share purchase warrants

As at August 28, 2020 there were no share purchase warrants outstanding.

Financial Statements

Fiscal Year 2020
2nd Quarter Report for the period ended June 30, 2020 FS MD&A
1st Quarter Report for the period ended March 31, 2020 FS MD&A
Fiscal Year 2019
Audited Annual Financial Statements for the year ended December 31, 2019 FS MD&A
3rd Quarter Report for the period ended September 30, 2019 FS MD&A
2nd Quarter Report for the period ended June 30, 2019 FS MD&A
1st Quarter Report for the period ended March 31, 2019 FS MD&A
Fiscal Year 2018
Audited Annual Financial Statements for the year ended December 31, 2018 FS MD&A
3rd Quarter Report for the period ended September 30, 2018 FS MD&A
2nd Quarter Report for the period ended June 30, 2018 FS MD&A
1st Quarter Report for the period ended March 31, 2018 FS MD&A
Fiscal Year 2017
Audited Annual Financial Statements for the year ended December 31, 2017 FS MD&A
3rd Quarter Report for the period ended September 30, 2017 FS MD&A
2nd Quarter Report for the period ended June 30, 2017 FS MD&A
1st Quarter Report for the period ended March 31, 2017 FS MD&A
Fiscal Year 2016
Audited Annual Financial Statements for the year ended December 31, 2016 FS MD&A
3rd Quarter Report for the period ended September 30, 2016 FS MD&A
2nd Quarter Report for the period ended June 30, 2016 FS MD&A
1st Quarter Report for the period ended March 31, 2016 FS MD&A
Fiscal Year 2015
Audited Annual Financial Statements for the year ended December 31, 2015 FS MD&A
3rd Quarter Report for the period ended September 30, 2015 FS MD&A
2nd Quarter Report for the period ended June 30, 2015 FS MD&A
1st Quarter Report for the period ended March 31, 2015 FS MD&A
Fiscal Year 2014
Audited Annual Financial Statements for the year ended December 31, 2014 FS MD&A
3rd Quarter Report for the period ended September 30, 2014 FS MD&A
2nd Quarter Report for the period ended June 30, 2014 FS MD&A
1st Quarter Report for the period ended March 31, 2014 FS MD&A
Fiscal Year 2013
Audited Annual Financial Statements for the year ended December 31, 2013 FS MD&A
3rd Quarter Report for the period ended September 30, 2013 FS MD&A
2nd Quarter Report for the period ended June 30, 2013 FS MD&A
1st Quarter Report for the period ended March 31, 2013 FS MD&A
Fiscal Year 2012
Audited Annual Financial Statements for the year ended December 31, 2012 FS MD&A
3rd Quarter Report for the period ended September 30, 2012 FS MD&A
2nd Quarter Report for the period ended June 30, 2012 FS MD&A
1st Quarter Report for the period ended March 31, 2012 FS MD&A
Fiscal Year 2011
Audited Annual Financial Statements for the year ended December 31, 2011 FS MD&A

Contact Investor Information